DE69232890T2 - Regulierung der systemischen immunantworten mittels zytokinen und antigenen - Google Patents

Regulierung der systemischen immunantworten mittels zytokinen und antigenen

Info

Publication number
DE69232890T2
DE69232890T2 DE69232890T DE69232890T DE69232890T2 DE 69232890 T2 DE69232890 T2 DE 69232890T2 DE 69232890 T DE69232890 T DE 69232890T DE 69232890 T DE69232890 T DE 69232890T DE 69232890 T2 DE69232890 T2 DE 69232890T2
Authority
DE
Germany
Prior art keywords
systemic immune
antigen
antigens
immune response
cytokins
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69232890T
Other languages
English (en)
Other versions
DE69232890D1 (de
Inventor
Glenn Dranoff
Richard C Mulligan
Drew Pardoll
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Whitehead Institute for Biomedical Research
Johns Hopkins University
School of Medicine of Johns Hopkins University
Original Assignee
Whitehead Institute for Biomedical Research
Johns Hopkins University
School of Medicine of Johns Hopkins University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25091012&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69232890(T2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Whitehead Institute for Biomedical Research, Johns Hopkins University, School of Medicine of Johns Hopkins University filed Critical Whitehead Institute for Biomedical Research
Application granted granted Critical
Publication of DE69232890D1 publication Critical patent/DE69232890D1/de
Publication of DE69232890T2 publication Critical patent/DE69232890T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A61K39/00119—Melanoma antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69232890T 1991-10-04 1992-10-05 Regulierung der systemischen immunantworten mittels zytokinen und antigenen Expired - Lifetime DE69232890T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77119491A 1991-10-04 1991-10-04
PCT/US1992/008455 WO1993006867A1 (en) 1991-10-04 1992-10-05 The regulation of systemic immune responses utilizing cytokines and antigens

Publications (2)

Publication Number Publication Date
DE69232890D1 DE69232890D1 (de) 2003-02-13
DE69232890T2 true DE69232890T2 (de) 2003-10-09

Family

ID=25091012

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69232890T Expired - Lifetime DE69232890T2 (de) 1991-10-04 1992-10-05 Regulierung der systemischen immunantworten mittels zytokinen und antigenen
DE69233614T Expired - Lifetime DE69233614T2 (de) 1991-10-04 1992-10-05 Regulierung der systemischen Immunantworten mittels Zytokinen und Antigenen

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE69233614T Expired - Lifetime DE69233614T2 (de) 1991-10-04 1992-10-05 Regulierung der systemischen Immunantworten mittels Zytokinen und Antigenen

Country Status (8)

Country Link
EP (2) EP1216710B1 (de)
JP (1) JP3580371B2 (de)
AT (2) ATE322286T1 (de)
AU (1) AU677165B2 (de)
CA (1) CA2120503C (de)
DE (2) DE69232890T2 (de)
ES (1) ES2189788T3 (de)
WO (1) WO1993006867A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5662896A (en) * 1988-03-21 1997-09-02 Chiron Viagene, Inc. Compositions and methods for cancer immunotherapy
US5902576A (en) * 1992-10-22 1999-05-11 Yeda Research And Development Co. Ltd. At Weizmann Institute Of Science Antitumor pharmaceutical composition comprising IL-6 transfected cells
FR2710536B1 (fr) * 1993-09-29 1995-12-22 Transgene Sa Usage anti-cancéreux d'un vecteur viral comportant un gène modulateur de la réponse immunitaire et/ou inflammatoire.
CA2178902A1 (en) * 1993-12-14 1995-06-22 Drew Pardoll Controlled release of pharmaceutically active substances for immunotherapy
US5478556A (en) * 1994-02-28 1995-12-26 Elliott; Robert L. Vaccination of cancer patients using tumor-associated antigens mixed with interleukin-2 and granulocyte-macrophage colony stimulating factor
FR2725726B1 (fr) * 1994-10-17 1997-01-03 Centre Nat Rech Scient Vecteurs viraux et utilisation en therapie genique
WO1996021015A2 (en) * 1994-12-30 1996-07-11 Chiron Corporation Combination gene delivery vehicles
US6372208B1 (en) 1999-09-28 2002-04-16 The Trustees Of The University Of Pennsylvania Method of reducing an immune response to a recombinant virus
US6251957B1 (en) 1995-02-24 2001-06-26 Trustees Of The University Of Pennsylvania Method of reducing an immune response to a recombinant virus
WO1997000085A1 (en) * 1995-06-19 1997-01-03 University Of Medicine & Dentistry Of New Jersey Gene therapy of solid tumors with interferons alone or with other immuno-effector proteins
US5837231A (en) * 1996-06-27 1998-11-17 Regents Of The University Of Minnesota GM-CSF administration for the treatment and prevention of recurrence of brain tumors
AU3889997A (en) 1996-08-16 1998-03-06 Johns Hopkins University School Of Medicine, The Melanoma cell lines expressing shared immunodominant melanoma antigens nd methods of using same
EP0834323A1 (de) * 1996-09-30 1998-04-08 Introgene B.V. Cytokin-Gentherapie für die Behandlung von malignen Tumoren
GB9827104D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
ATE421328T1 (de) * 2002-02-22 2009-02-15 Intracel Recources Llc Sterile immunogene nicht-tumorigene tumorzell- zusammensetzungen und verfahren
US7176022B2 (en) 2002-12-20 2007-02-13 Cell Genesys, Inc. Directly injectable formulations which provide enhanced cryoprotection of cell products
US20050019336A1 (en) 2003-07-23 2005-01-27 Dalgleish Angus George Human prostate cell lines in cancer treatment
RU2354694C2 (ru) * 2003-12-30 2009-05-10 Мологен Аг Аллогенное противоопухолевое терапевтическое средство

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3875859T2 (de) * 1987-03-02 1993-05-13 Genetics Inst Zubereitungen zur verbesserung der adcc-therapien.
DE3922444A1 (de) * 1988-03-01 1991-01-10 Deutsches Krebsforsch Virusmodifizierte tumorvakzine fuer die immuntherapie von tumormetastasen
DE3806565A1 (de) * 1988-03-01 1989-09-14 Deutsches Krebsforsch Virusmodifizierte tumorvakzinen fuer die immuntherapie von tumormetastasen
CA2091346C (en) * 1990-09-14 2007-04-24 Philip Frost Methods and compositions for genetic therapy and potentiation of anti-tumor immunity
AU656544B2 (en) * 1990-10-31 1995-02-09 Brigham And Women's Hospital Genetic modification of endothelial cells

Also Published As

Publication number Publication date
EP0607309B1 (de) 2003-01-08
EP1216710A1 (de) 2002-06-26
WO1993006867A1 (en) 1993-04-15
DE69233614D1 (de) 2006-05-18
DE69233614T2 (de) 2007-02-15
JPH07502987A (ja) 1995-03-30
JP3580371B2 (ja) 2004-10-20
EP1216710B1 (de) 2006-04-05
AU677165B2 (en) 1997-04-17
EP0607309A1 (de) 1994-07-27
AU2777692A (en) 1993-05-03
CA2120503C (en) 2006-04-04
ATE230615T1 (de) 2003-01-15
ES2189788T3 (es) 2003-07-16
DE69232890D1 (de) 2003-02-13
ATE322286T1 (de) 2006-04-15
CA2120503A1 (en) 1993-04-15

Similar Documents

Publication Publication Date Title
DE69232890T2 (de) Regulierung der systemischen immunantworten mittels zytokinen und antigenen
ES2092306T3 (es) Adyuvante para vacunas.
NO914115L (no) Fremgangsmaate for fremstilling av peroksidiske perfluorpolyetere
DE69018990D1 (de) Stabile interleukine enthaltende impfstoffzusammensetzungen.
FI851859A0 (fi) Antigenpreparat och isolering av saodana preparat.
FI891283A (fi) Ifosfamid-mesna-lyofilisat och foerfarande foer dess framstaellning.
DE69027750T2 (de) Überschallgeschoss mit Lenkung mittels paarweise wirkenden Luftbremsen
IT8049531A0 (it) Procedimento per controllare la ve locita' di dissoluzione di polimeri vinilici idrosolubili ad alto peso molecolare
DE69112968T2 (de) Aufbau eines regelbaren dämpfers.
FI924424A (fi) Hjaertskyddande tokoferolanaloger
FI892222A (fi) Peptidalkoholer med antikoagulantverkan.
IT8049162A0 (it) Belli poltrone e simili dispositivo per trasmissione aerea di impulsi ultrasuonici atto alla regolazione della posizione di sga
DE3867220D1 (de) Gasleit der schalldaempfungseinrichtung fuer drehkolbenverdichter.
ITMI920879A0 (it) Determinazione della velocita' di volo reale di missili
NO922304D0 (no) Eliminering av aktiverte lymfocytter
DE69118955T2 (de) Ascorbinsäure Derivate
DK0542895T3 (da) Krydsreaktiv influenza A immunisering
DE60042827D1 (de) Cytokine aus säugetieren und dazugehörende reagenzien
ATE60765T1 (de) Pyranderivate.
FI921474A0 (fi) Antimetastatiskt fungerande aemnen.
GB9117006D0 (en) Device for dolls,activator of head movement,voice sound and light
EP0563288A4 (en) Immunopotentiation of vaccines, particularly swine pleuropneumonia vaccines
WO1990015132A3 (en) Cloned treponema hyodysenteriae endoflagellar antigen
IT8430790V0 (it) Dispositivo orientabile per i comandi di movimento delle poltrone particolarmente per dentisti.
SE8600411L (sv) Isokinolinderivat, deras framstellning och anvendning

Legal Events

Date Code Title Description
8363 Opposition against the patent
8365 Fully valid after opposition proceedings
R071 Expiry of right

Ref document number: 607309

Country of ref document: EP